Healthy NewbornsNCT07410910
The Effect of Four Different Methods Used During Body Weight Measurement in Newborns on Comfort and Physiological Variables
A study testing Routine Care, Swaddling and Holding in people with Healthy Newborns and Comfort in Neonates, run by Mersin University at 1 site in Turkey (Türkiye).
Trial summary
The study, planned to be conducted in a single-center, parallel-armed, randomized experimental design, aims to determine the effect of four different methods (Routine Care, Holding, Swaddling, Swaddling + Holding) on comfort scores as the primary outcome and on heart rate (HR) and peripheral capillary oxygenation… Read more about this study
- Who is it for?
- Ages 0 to 28 daysHealthy volunteers can take part
- Conditions the study is for
- Healthy Newborns, Comfort in Neonates
- What is being tested?
- Routine Care, Swaddling and Holding
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 96 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 13 Feb 2026to 3 Mar 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 0 to 28 days
- All sexes
- Healthy volunteers accepted
- Child
Who may be able to join
- Body weight measurement is planned as part of follow-up at the Mersin University Hospital Newborn Follow-up Clinic,
- The parent gives consent for the baby and themselves to participate in the study,
- The parent's body weight is less than 100 kg,
- The newborn's birth weight is 2500 g or more,
- The newborn's gestational age at birth is less than 37 weeks,
- The newborn's postnatal age is 28 days or less,
- The newborn is physiologically stable
Who cannot join
- The newborn has undergone surgery,
- The newborn has a genetic, metabolic, or congenital disorder,
- The newborn has a neuroendocrine disorder,
- The newborn's gestational age at birth is greater than 37 weeks,
- The newborn's postnatal age is greater than 28 days.
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Mersin University Hospital
Mersin, Province, 33343
About this study
The study, planned to be conducted in a single-center, parallel-armed, randomized experimental design, aims to determine the effect of four different methods (Routine Care, Holding, Swaddling, Swaddling + Holding) on comfort scores as the primary outcome and on heart rate (HR) and peripheral capillary oxygenation (SaPO2) as secondary outcomes.
Research hypotheses
Primary Hypothesis:
H1/1: There is a difference between the mean comfort scores of the groups.
Secondary Hypothesis:
H1/2: There is a difference between the mean HR values of the groups. H1/3: There is a difference between the mean SaPO2 values of the groups.
Read the detailed description
Aim: The study, planned to be conducted in a single-center, parallel-armed, randomized experimental design, aims to determine the effect of four different methods (Routine Care, Holding, Swaddling, Swaddling + Holding) on comfort scores as the primary outcome and on heart rate (HR) and peripheral capillary oxygenation (SaPO2) as secondary outcomes.
Research hypotheses
Primary Hypothesis:
H1/1: There is a difference between the mean comfort scores of the groups.
Secondary Hypothesis:
H1/2: There is a difference between the mean HR values of the groups. H1/3: There is a difference between the mean SaPO2 values of the groups.
Variables of the study: The COMFORTneo scores, HR, and SaPO2 values of newborns are the dependent variables of the study. The methods of "Routine Care," "Holding," "Swaddling," and "Swaddling + Holding" are the independent variables of the study. The sex, birth weight, current weight, gestational age, postnatal age, etc. of newborns are control variables.
Location and characteristics of the research site: The research is planned to be conducted between February 14 and 21 Mart 2026, at the Neonatal Follow-up Clinic of Mersin University Hospital, a tertiary healthcare facility. The clinic is open from 8 a.m. to 4 p.m., and routine measurements of newborns' body weight are performed as part of follow-up care.
Research population and sample: Newborns scheduled for routine body weight measurements as part of follow-up appointments will be seen at the Mersin University Hospital Neonatal Follow-Up Clinic. The sample size was determined using a priori power analysis. The effect size (d=1.17) from the study "The effect of three different methods applied during peripheral vascular access in preterm infants on pain and comfort levels" was used as the basis for the analysis. Accordingly, the required sample size was calculated as 20 newborns for each group to ensure that the difference between the comfort score averages of at least two of the groups would be statistically significant with a maximum of 5% type I error (α = 0.05) and at least 90% power (1-β = 0.90). Considering that losses may occur during the research process, the sample size was increased by 20%, and the sample size of 96 newborns was calculated, with 24 newborns in each group.
Inclusion Criteria for the Study:
- Body weight measurement is planned as part of follow-up at the Mersin University Hospital Newborn Follow-up Clinic,
- The parent gives consent for the baby and themselves to participate in the study,
- The parent's body weight is less than 100 kg,
- The newborn's birth weight is 2500 g or more,
- The newborn's gestational age at birth is less than 37 weeks,
- The newborn's postnatal age is 28 days or less,
- The newborn is physiologically stable.
Exclusion Criteria from the Study:
- The newborn has undergone surgery,
- The newborn has a genetic, metabolic, or congenital disorder,
- The newborn has a neuroendocrine disorder,
- The newborn's gestational age at birth is greater than 37 weeks,
- The newborn's postnatal age is greater than 28 days.
Randomization and blinding To maintain balance between groups, the block randomization method will be preferred. Using a simple random selection method (randomizer.org), 16 blocks will be selected from 24 different block combinations with block size 6 containing codes A, B, C, and D (AADDCCBB, DDAABBCC, DBCCAABD) to create a random assignment sequence (1-96). Each newborn will be numbered according to the order of intervention and placed in opaque sealed envelopes. Parents will be blinded to the intervention groups during the application and evaluation period. The implementer and evaluator will be blinded to the research hypotheses. Data entry, analysis, and reporting will be performed by a researcher unaware of the intervention groups using the codes A, B, C, and D. After statistical analysis is completed and the research report is written, the coding for the intervention groups will be disclosed to the relevant researcher.
Data collection tools: The Newborn Information and Observation Form and the COMFORTneo will be used to collect research data. A monitor and compatible pulse oximeter, camera, termometer and sheets as wrapping material will be used as data collection tools.
Newborn Information and Observation Form: Developed by researchers after a literature review, the Newborn Information and Observation Form consists of multiple-choice and open-ended questions. It includes questions such as the newborn's gender, birth weight, gestational age at birth, postnatal age, and whether they experienced procedural pain in the last 24 hours prior to the procedure etc.
Comfort Scale (COMFORTNeo): TIt is a Likert-type scale consisting of six parameters: alertness, calmness/agitation, respiratory response, crying, body movements, facial tension, and muscle tone. In newborns receiving mechanical ventilator support, the "Respiratory Response" item is evaluated, while in those not receiving mechanical ventilator support, the "Crying" item is evaluated. Each item on the scale is scored from 1 to 5. It is evaluated based on the total score. The lowest possible score on the Neonatal Comfort Behavior Scale (NCBS) is 6, and the highest possible score is 30. If the total scale score is between 14 and 30, it is emphasized that the infant is in pain or distress, is uncomfortable, and requires interventions to provide comfort.
Monitor and Pulse Oximeter: The monitor located in the outpatient clinic and the compatible pulse oximeter sensor will be used for measuring the newborn's heart rate (beats/min) and SaPO2 (%) before, during, and after the procedure.
Camera: A portable tablet will be used to record video throughout all stages of the procedure, capturing "the baby's face and behavior" and "the HR and SaPO2 values on the monitor."
Thermometer: It will be used to monitor the body temperature of newborns before, during, and after procedures to assess the safety of interventions.
Preliminary application and implementation of the study: The application steps will be performed on a mannequin before research data collection begins. Subsequently, a pre-application will be performed on 4 newborns who are not included in the research but for whom routine body weight measurement is planned. The parents of newborns who meet the inclusion criteria will be informed about the purpose and process of the study, and the participant information and consent form will be read to them. Written consent will be obtained from parents who wish for their baby and themselves to participate in the study.
The information on the Neonatal Information and Observation Form (gender, birth weight, gestational age at birth, postnatal age, experience of procedural pain in the last 24 hours prior to the procedure, sleep-wake status) will be completed by the evaluator from the file 10 minutes before the procedure, after obtaining written consent from the parent. Video recording will begin 7 minutes before the procedure, and a pulse oximeter will be placed on the newborn's right palm. The camera angle will be adjusted so that "the baby's face and behavioral responses can be seen" and "the KAH and SaPO2 values on the monitor can be read." The practitioner will remove the newborn's clothing, leaving only the diaper on, and attach the pulse oximeter probe to the palmar area of the right hand. Video recording will continue for 5 minutes after all procedures are completed. During this time, the evaluator will record the newborn's body weight, comfort before, during, and after the procedure, and KAH and SaPO2 values on the Newborn Information and Observation Form. The comfort score measured during the procedure will be considered indicative of the stress response, while the comfort scores at 1 and 2 minutes after the procedure will be considered indicative of stress regulation. The video recordings will be sent to a second evaluator who is a certified neonatal nurse for COMFORTneo and a scientific expert.
Implementation of Procedures:
Routine care: Resetting the scale, safely placing the newborn on the baby scale, weighing, and removing from the scale Swaddling: Swaddling the newborn using a safe technique, resetting the scale, safely placing the newborn on the baby scale, weighing, and removing from the scale Holding: Safe holding of the newborn by the parent, resetting the scale, weighing the newborn on an adult scale while held by the parent, and weighing only the parent on the adult scale Swaddling + Holding: Swaddling the newborn safely, the parent safely holding the newborn, resetting the scale, weighing the newborn on the adult scale while in the parent's arms, only the parent stepping on the adult scale and being weighed.
Data analysis and evaluation: Statistical package programs will be used in data analysis and visualization of results. The statistical significance level will be set at ≤0.05. Depending on whether the scale scores show a normal distribution, parametric or non-parametric tests will be used to compare differences between means according to interventions.
Ethical considerations of the study: The necessary permissions for the Turkish version of the comfort scale to be used in the data collection process have been obtained via email. Ethical approval will be obtained from the Mersin University Rectorate Clinical Research Ethics Committee and written institutional permission will be obtained from Mersin University Hospital for the study. The research protocol will be prospectively registered on clinicaltrials.gov. Information will be provided on the purpose, duration, and implementation of the research, and written consent will be obtained from the parents of newborns for both their babies (Legal Representative Informed Consent Form) and themselves (Adult Informed Consent Form).
- Conditions
- Healthy Newborns, Comfort in Neonates
- Being tested
- Routine Care, Swaddling, Holding, Swaddling + Holding
- Keywords
- neonates, body weight measurement, comfort
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Routine CareOther
Resetting the scale, safely placing the newborn on the baby scale, weighing them, and removing them from the scale
SwaddlingBehavioural
Swaddling: Swaddling the newborn using a safe technique, resetting the scale, safely placing the newborn on the baby scale, weighing them, and removing them from the scale.
HoldingOther
Holding the baby: The parent safely holding the newborn, resetting the scale, weighing the newborn on the parent's lap on an adult scale, and then the parent stepping onto the adult scale and being weighed.
Swaddling + HoldingBehavioural
Swaddling + Holding: Swaddling the newborn using a safe technique, the parent safely holding the newborn, resetting the scale, weighing the newborn on an adult scale while in the parent's arms, and only the parent stepping on the adult scale and being weighed.
| Study group | Role | What they receive |
|---|---|---|
| Routine Care | Active comparator | Routine Care Receives: Other: Routine Care |
| Holding | Active comparator | Holding Receives: Other: Holding |
| Swaddling | Active comparator | Swaddling Receives: Behavioral: Swaddling |
| Swaddling + Holding | Active comparator | Swaddling + Holding Receives: Behavioral: Swaddling + Holding |
What is being measured
The primary outcome is the main question the study is designed to answer.
COMFORTneo scores during the procedure
Turkis version of COMFORTneo consists of six behavioral items (alertness, calmness/agitation, respiratory response, crying, body movement, facial tension, and muscle tone), of which six items should be scored (respiratory response or crying depends on the presence of invasive ventilation). Each item has a score range of 1 to 5 and the total score ranges from 6 to 30. Higher values represent lower comfort.
Measured: during the body weight measurement procedure
COMFORTneo scores after the procedure
Turkis version of COMFORTneo consists of six behavioral items (alertness, calmness/agitation, respiratory response, crying, body movement, facial tension, and muscle tone), of which six items should be scored (respiratory response or crying depends on the presence of invasive ventilation). Each item has a score range of 1 to 5 and the total score ranges from 6 to 30. Higher values represent lower comfort.
Measured: 2 minutes after the body weight measurement procedure
Secondary outcomes (4)
Heart rate during the procedure
Heart rate will be measured as a physiological variable in parallel with the newborn's comfort score.
Measured: during the body weight measurement
Heart rate after the procedure
Heart rate will be measured as a physiological variable in parallel with the newborn's comfort score.
Measured: 2 minutes after the body weight measurement
Oxygen saturation during the procedure
SPO2 will be measured as a physiological variable in parallel with the newborn's comfort score.
Measured: during the body weight measurement
Oxygen saturation after the procedure
SPO2 will be measured as a physiological variable in parallel with the newborn's comfort score.
Measured: 2 minutes after the body weight measurement
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Feb 2026
- Study start13 Feb 2026
- Primary completion3 Mar 2026
- Study completion3 Mar 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Healthy NewbornsStudies of the same condition, open and under way.
- More trials run by Mersin UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Outcomes assessor
- Enrolment
- 96 participants (actual)
Sponsor and investigators
- Lead sponsor
- Mersin University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Guzide UGUCU, Mersin University
- Investigators
- GUZIDE UGUCU, RN, MScN, PhD, Principal investigator, Mersin University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07410910
- Sponsor's protocol ID
- MersinU*GUGUCU_005
- Status last verified
- Mar 2026
- First submitted
- 2 Feb 2026
- Last updated
- 5 Mar 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: There is not a plan to make IPD available.
Study at a glance
From the registry record, last updated by the sponsor on 5 Mar 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Effect of Four Different Methods Used During Body Weight Measurement in Newborns on Comfort and Physiological Variables
- ClinicalTrials.gov ID
- NCT07410910
- Acronym / sponsor ID
- MersinU*GUGUCU_005
- Conditions
- Healthy Newborns, Comfort in Neonates
- Keywords
- neonates, body weight measurement, comfort
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 96 participants (actual)
- Lead sponsor
- Mersin UniversityUniversity, hospital or other
- Study start
- 13 Feb 2026 (actual)
- Primary completion
- 3 Mar 2026 (actual)
- Study completion
- 3 Mar 2026 (actual)
- First posted
- 13 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The study, planned to be conducted in a single-center, parallel-armed, randomized experimental design, aims to determine the effect of four different methods (Routine Care, Holding, Swaddling, Swaddling + Holding) on comfort scores as the primary outcome and on heart rate (HR) and peripheral capillary oxygenation (SaPO2) as secondary outcomes.
Research hypotheses
Primary Hypothesis:
H1/1: There is a difference between the mean comfort scores of the groups.
Secondary Hypothesis:
H1/2: There is a difference between the mean HR values of the groups. H1/3: There is a difference between the mean SaPO2 values of the groups.
Detailed description
Aim: The study, planned to be conducted in a single-center, parallel-armed, randomized experimental design, aims to determine the effect of four different methods (Routine Care, Holding, Swaddling, Swaddling + Holding) on comfort scores as the primary outcome and on heart rate (HR) and peripheral capillary oxygenation (SaPO2) as secondary outcomes.
Research hypotheses
Primary Hypothesis:
H1/1: There is a difference between the mean comfort scores of the groups.
Secondary Hypothesis:
H1/2: There is a difference between the mean HR values of the groups. H1/3: There is a difference between the mean SaPO2 values of the groups.
Variables of the study: The COMFORTneo scores, HR, and SaPO2 values of newborns are the dependent variables of the study. The methods of "Routine Care," "Holding," "Swaddling," and "Swaddling + Holding" are the independent variables of the study. The sex, birth weight, current weight, gestational age, postnatal age, etc. of newborns are control variables.
Location and characteristics of the research site: The research is planned to be conducted between February 14 and 21 Mart 2026, at the Neonatal Follow-up Clinic of Mersin University Hospital, a tertiary healthcare facility. The clinic is open from 8 a.m. to 4 p.m., and routine measurements of newborns' body weight are performed as part of follow-up care.
Research population and sample: Newborns scheduled for routine body weight measurements as part of follow-up appointments will be seen at the Mersin University Hospital Neonatal Follow-Up Clinic. The sample size was determined using a priori power analysis. The effect size (d=1.17) from the study "The effect of three different methods applied during peripheral vascular access in preterm infants on pain and comfort levels" was used as the basis for the analysis. Accordingly, the required sample size was calculated as 20 newborns for each group to ensure that the difference between the comfort score averages of at least two of the groups would be statistically significant with a maximum of 5% type I error (α = 0.05) and at least 90% power (1-β = 0.90). Considering that losses may occur during the research process, the sample size was increased by 20%, and the sample size of 96 newborns was calculated, with 24 newborns in each group.
Inclusion Criteria for the Study:
- Body weight measurement is planned as part of follow-up at the Mersin University Hospital Newborn Follow-up Clinic,
- The parent gives consent for the baby and themselves to participate in the study,
- The parent's body weight is less than 100 kg,
- The newborn's birth weight is 2500 g or more,
- The newborn's gestational age at birth is less than 37 weeks,
- The newborn's postnatal age is 28 days or less,
- The newborn is physiologically stable.
Exclusion Criteria from the Study:
- The newborn has undergone surgery,
- The newborn has a genetic, metabolic, or congenital disorder,
- The newborn has a neuroendocrine disorder,
- The newborn's gestational age at birth is greater than 37 weeks,
- The newborn's postnatal age is greater than 28 days.
Randomization and blinding To maintain balance between groups, the block randomization method will be preferred. Using a simple random selection method (randomizer.org), 16 blocks will be selected from 24 different block combinations with block size 6 containing codes A, B, C, and D (AADDCCBB, DDAABBCC, DBCCAABD) to create a random assignment sequence (1-96). Each newborn will be numbered according to the order of intervention and placed in opaque sealed envelopes. Parents will be blinded to the intervention groups during the application and evaluation period. The implementer and evaluator will be blinded to the research hypotheses. Data entry, analysis, and reporting will be performed by a researcher unaware of the intervention groups using the codes A, B, C, and D. After statistical analysis is completed and the research report is written, the coding for the intervention groups will be disclosed to the relevant researcher.
Data collection tools: The Newborn Information and Observation Form and the COMFORTneo will be used to collect research data. A monitor and compatible pulse oximeter, camera, termometer and sheets as wrapping material will be used as data collection tools.
Newborn Information and Observation Form: Developed by researchers after a literature review, the Newborn Information and Observation Form consists of multiple-choice and open-ended questions. It includes questions such as the newborn's gender, birth weight, gestational age at birth, postnatal age, and whether they experienced procedural pain in the last 24 hours prior to the procedure etc.
Comfort Scale (COMFORTNeo): TIt is a Likert-type scale consisting of six parameters: alertness, calmness/agitation, respiratory response, crying, body movements, facial tension, and muscle tone. In newborns receiving mechanical ventilator support, the "Respiratory Response" item is evaluated, while in those not receiving mechanical ventilator support, the "Crying" item is evaluated. Each item on the scale is scored from 1 to 5. It is evaluated based on the total score. The lowest possible score on the Neonatal Comfort Behavior Scale (NCBS) is 6, and the highest possible score is 30. If the total scale score is between 14 and 30, it is emphasized that the infant is in pain or distress, is uncomfortable, and requires interventions to provide comfort.
Monitor and Pulse Oximeter: The monitor located in the outpatient clinic and the compatible pulse oximeter sensor will be used for measuring the newborn's heart rate (beats/min) and SaPO2 (%) before, during, and after the procedure.
Camera: A portable tablet will be used to record video throughout all stages of the procedure, capturing "the baby's face and behavior" and "the HR and SaPO2 values on the monitor."
Thermometer: It will be used to monitor the body temperature of newborns before, during, and after procedures to assess the safety of interventions.
Preliminary application and implementation of the study: The application steps will be performed on a mannequin before research data collection begins. Subsequently, a pre-application will be performed on 4 newborns who are not included in the research but for whom routine body weight measurement is planned. The parents of newborns who meet the inclusion criteria will be informed about the purpose and process of the study, and the participant information and consent form will be read to them. Written consent will be obtained from parents who wish for their baby and themselves to participate in the study.
The information on the Neonatal Information and Observation Form (gender, birth weight, gestational age at birth, postnatal age, experience of procedural pain in the last 24 hours prior to the procedure, sleep-wake status) will be completed by the evaluator from the file 10 minutes before the procedure, after obtaining written consent from the parent. Video recording will begin 7 minutes before the procedure, and a pulse oximeter will be placed on the newborn's right palm. The camera angle will be adjusted so that "the baby's face and behavioral responses can be seen" and "the KAH and SaPO2 values on the monitor can be read." The practitioner will remove the newborn's clothing, leaving only the diaper on, and attach the pulse oximeter probe to the palmar area of the right hand. Video recording will continue for 5 minutes after all procedures are completed. During this time, the evaluator will record the newborn's body weight, comfort before, during, and after the procedure, and KAH and SaPO2 values on the Newborn Information and Observation Form. The comfort score measured during the procedure will be considered indicative of the stress response, while the comfort scores at 1 and 2 minutes after the procedure will be considered indicative of stress regulation. The video recordings will be sent to a second evaluator who is a certified neonatal nurse for COMFORTneo and a scientific expert.
Implementation of Procedures:
Routine care: Resetting the scale, safely placing the newborn on the baby scale, weighing, and removing from the scale Swaddling: Swaddling the newborn using a safe technique, resetting the scale, safely placing the newborn on the baby scale, weighing, and removing from the scale Holding: Safe holding of the newborn by the parent, resetting the scale, weighing the newborn on an adult scale while held by the parent, and weighing only the parent on the adult scale Swaddling + Holding: Swaddling the newborn safely, the parent safely holding the newborn, resetting the scale, weighing the newborn on the adult scale while in the parent's arms, only the parent stepping on the adult scale and being weighed.
Data analysis and evaluation: Statistical package programs will be used in data analysis and visualization of results. The statistical significance level will be set at ≤0.05. Depending on whether the scale scores show a normal distribution, parametric or non-parametric tests will be used to compare differences between means according to interventions.
Ethical considerations of the study: The necessary permissions for the Turkish version of the comfort scale to be used in the data collection process have been obtained via email. Ethical approval will be obtained from the Mersin University Rectorate Clinical Research Ethics Committee and written institutional permission will be obtained from Mersin University Hospital for the study. The research protocol will be prospectively registered on clinicaltrials.gov. Information will be provided on the purpose, duration, and implementation of the research, and written consent will be obtained from the parents of newborns for both their babies (Legal Representative Informed Consent Form) and themselves (Adult Informed Consent Form).
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, outcomes assessor)
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Routine Care | Active comparator | Other: Routine CareRoutine Care |
| Holding | Active comparator | Other: HoldingHolding |
| Swaddling | Active comparator | Behavioral: SwaddlingSwaddling |
| Swaddling + Holding | Active comparator | Behavioral: Swaddling + HoldingSwaddling + Holding |
Who may qualify
- Ages
- 0 to 28 days
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Child
Key inclusion criteria (7 listed)
- Body weight measurement is planned as part of follow-up at the Mersin University Hospital Newborn Follow-up Clinic,
- The parent gives consent for the baby and themselves to participate in the study,
- The parent's body weight is less than 100 kg,
- The newborn's birth weight is 2500 g or more,
- The newborn's gestational age at birth is less than 37 weeks,
Key exclusion criteria (5 listed)
- The newborn has undergone surgery,
- The newborn has a genetic, metabolic, or congenital disorder,
- The newborn has a neuroendocrine disorder,
- The newborn's gestational age at birth is greater than 37 weeks,
- The newborn's postnatal age is greater than 28 days.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Routine CareResetting the scale, safely placing the newborn on the baby scale, weighing them, and removing them from the scale | Other | Routine Care |
| SwaddlingSwaddling: Swaddling the newborn using a safe technique, resetting the scale, safely placing the newborn on the baby scale, weighing them, and removing them from the scale. | Behavioural | Swaddling |
| HoldingHolding the baby: The parent safely holding the newborn, resetting the scale, weighing the newborn on the parent's lap on an adult scale, and then the parent stepping onto the adult scale and being weighed. | Other | Holding |
| Swaddling + HoldingSwaddling + Holding: Swaddling the newborn using a safe technique, the parent safely holding the newborn, resetting the scale, weighing the newborn on an adult scale while in the parent's arms, and only the parent stepping on the adult scale and being weighed. | Behavioural | Swaddling + Holding |
Primary outcome
COMFORTneo scores during the procedure
Time frame: during the body weight measurement procedure
Turkis version of COMFORTneo consists of six behavioral items (alertness, calmness/agitation, respiratory response, crying, body movement, facial tension, and muscle tone), of which six items should be scored (respiratory response or crying depends on the presence of invasive ventilation). Each item has a score range of 1 to 5 and the total score ranges from 6 to 30. Higher values represent lower comfort.
COMFORTneo scores after the procedure
Time frame: 2 minutes after the body weight measurement procedure
Turkis version of COMFORTneo consists of six behavioral items (alertness, calmness/agitation, respiratory response, crying, body movement, facial tension, and muscle tone), of which six items should be scored (respiratory response or crying depends on the presence of invasive ventilation). Each item has a score range of 1 to 5 and the total score ranges from 6 to 30. Higher values represent lower comfort.
4 secondary outcomes
Heart rate during the procedure
Time frame: during the body weight measurement
Heart rate after the procedure
Time frame: 2 minutes after the body weight measurement
Oxygen saturation during the procedure
Time frame: during the body weight measurement
Oxygen saturation after the procedure
Time frame: 2 minutes after the body weight measurement
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 5 Mar 2026.
- Individual participant dataSharing planned: No. There is not a plan to make IPD available.
Related trials for Healthy Newborns
RecruitingPhase 1
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
Healthy Participants, Atopic Dermatitis
RecruitingPhase 2
Effects of Treatments on Atopic Dermatitis
Eczema, Dermatitis
RecruitingObservational study
Studies of Skin Microbes in Healthy People and in People With Skin Conditions
Eczema, Atopic Dermatitis
RecruitingPhase 1
A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis
Atopic Dermatitis (AD)
RecruitingObservational study
Comparison of Individuals With Primary Ciliary Dyskinesia and Healthy Controls
Primary Ciliary Dyskinesia (PCD)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
GUZIDE UGUCU, RN, MScN, PhD principal investigator
Mersin University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Routine Care, Swaddling and Holding in people with Healthy Newborns and Comfort in Neonates, run by Mersin University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 5 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
COMFORTneo scores during the procedure (time frame: during the body weight measurement procedure). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Mar 2026.